Drugs / clidinium

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) LIBRAX 1966-09-01 fda.gov

Trials 1 · a red edge is where a trial was stopped

today
US approved 1966
NCT00516854 · not/applicable
1965196619671968196919701971197219731974197519761977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT00516854 Jun 2002 → Dec 2008 Hospital Authority, Hong Kong Unknown No outcome recorded

Evidence & citations 14 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as clidinium ClinicalTrials.gov intervention name — accepted as the source's own label NCT00516854
Known as Bromure de clidinium ChEMBL registry synonym — accepted as the source's own label CHEMBL620
Known as Bromuro de clidinio ChEMBL registry synonym — accepted as the source's own label CHEMBL620
Known as CLIDINIUM BROMIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL620
Known as Clidinium bromide component of librax ChEMBL registry synonym — accepted as the source's own label CHEMBL620
Known as Clidinium cation ChEMBL registry synonym — accepted as the source's own label CHEMBL620
Known as Clidinium ion ChEMBL registry synonym — accepted as the source's own label CHEMBL620
Known as NSC-756686 ChEMBL registry synonym — accepted as the source's own label CHEMBL620
Known as Quarzan ChEMBL registry synonym — accepted as the source's own label CHEMBL620
Known as RO 2-3773 ChEMBL registry synonym — accepted as the source's own label CHEMBL620
Action Inhibit “Muscarinic acetylcholine receptor M3 antagonist” CHEMBL620
1

“Muscarinic acetylcholine receptor M1 antagonist” CHEMBL620

Modality Small molecule CHEMBL620
Target CHRM1 “Muscarinic acetylcholine receptor M1 antagonist” CHEMBL620
Target CHRM3 “Muscarinic acetylcholine receptor M3 antagonist” CHEMBL620